Interactive Investor

AstraZeneca joins Watchlist pipeline

Richard Beddard
Publish date: Wed, 20 Feb 2013, 10:22 AM
Richard Beddard
0 2,773
Following Message

The challenges facing big pharma are manifest, but partly of its own making. A new chief-executive at AstraZeneca could be the catalyst investors are looking for.

read more

Related Stocks
Market Buzz
More articles on Interactive Investor
Quartix: Love at first sight

Created by Richard Beddard | Mar 09, 2016

Howden Joinery: As simple as rolling out new depots

Created by Richard Beddard | Mar 08, 2016

Science: Mixed results mask value

Created by Richard Beddard | Mar 07, 2016

InterContinental Hotels: Asset light and cash heavy

Created by Richard Beddard | Feb 29, 2016

Tristel: Caught in the expectations trap

Created by Richard Beddard | Feb 26, 2016

Ten years of Wynnstay

Created by Richard Beddard | Feb 25, 2016

XP Power: Transformed

Created by Richard Beddard | Feb 23, 2016

ARM: Tech titan on sale

Created by Richard Beddard | Feb 22, 2016

Trading our way to FTSE 45,000

Created by Richard Beddard | Feb 19, 2016

The next bear market low is on 22 May

Created by Richard Beddard | Feb 19, 2016

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment